Here you can browse the report which was ordered by the House of Commons to be printed 8 January 2013.
Terms of Reference
Summary
1 Introduction
Background
2 Social care and integrated care
3 Health Technology Appraisals: cost effectiveness and other issues
Cost effectiveness and value-based pricing
Cancer Drugs Fund
Information about clinical drug trials
Patient voice
4 Clinical guidance and quality standards
Clinical guidance
Quality standards
Conclusions and recommendations
Formal Minutes
Witnesses
List of printed written evidence
List of additional written evidence
List of Reports from the Committee during the current Parliament Oral and Written Evidence
4 December 2012
27 November 2012
Written Evidence
Virtual Written Evidence